Search results
New Cancer 'Missile' Drugs May Be More Effective Than Traditional Chemotherapy
Verywell Health via Yahoo News· 5 days agoThe Food and Drug Administration (FDA) recently approved a “guided... clinical trials, patients who...
TAR-210 results show 90% recurrence-free survival and 90% complete response in patients with...
FOX 4 Kansas City· 2 days agoJohnson & Johnson announced today updated results from an open-label, multicenter, multi-cohort...
Rescue Seal Pup's Very First Swim Is Such a Joy to See
AOL· 7 days agoThe survival rate of baby seals is only about fifty percent, as they are extremely vulnerable in the wild. The researchers at the center suspect that this ...
Merck reports data from Phase III gastric cancer treatment trial
Clinical Trials Arena via Yahoo Finance· 6 days agoEnrolling 698 subjects, the trial...According to the latest data, the study met its dual primary...
ANIMAL CONNECTION: Kitten Count up to 98 at the SPCA Albrecht Center
The Post and Courier· 1 day agoFriday morning, staff at the SPCA Albrecht Center for Animal Welfare were greeted with an unexpected...
5 reasons to get colon checked at a young age
Rolling Out· 4 days agoColonoscopies are a vital screening tool for colorectal cancer, the second leading cause of cancer deaths in the United States. While most guidelines
Outdoors Turkey numbers look good for spring gobbler season
The Tribune-Democrat, Johnstown, Pa. via Yahoo Sports· 5 days agoMay 2—A mild winter and a great mast crop from this past autumn have set the stage for a promising spring gobbler season, which begins statewide Saturday. "The breeding is right on schedule, ...
TAR-210 results show 90% recurrence-free survival and 90% complete response in patients with...
Quad-City Times· 2 days agoJohnson & Johnson announced today updated results from an open-label, multicenter, multi-cohort Phase 1 study of the safety and efficacy of TAR-210, an intravesical targeted releasing system ...
Project Optimus: helping or hindering cancer drug development?
Clinical Trials Arena via Yahoo Finance· 6 days agoProject Optimus: apply with care In the existing model, a handful of patients are evaluated at a...
Pfizer Stock Is Near An 11-Year Low — But Is It A Buy On This 'Massive' Upside?
Investor's Business Daily· 6 days agoHemgenix gained U.S. approval in late 2022 and also costs $3.5 million before insurance deductions...